 |
 |
|
|
|
| Tranexamic acid |
 |
| C8H15NO2 99% |
 |
| 1197-18-8 |
 |
And bleeding similar to aromatic acid. Hemostatic, the marked effect of traumatic bleeding, preoperative preventive medication may reduce surgical bleeding
Main ingredients tranexamic acid.
Indications Treatment of hyperthyroidism caused by fibrinolytic bleeding, such as cirrhosis of intraoperative bleeding. There is also can be used for recurrent epistaxis, eye trauma hemorrhage, subarachnoid recurrent bleeding. Hemophilia patients with hereditary antiplasmin deficiency before and after the administration of tooth extraction can reduce the amount of clotting factor infusion.
Use of hemostatic products, the marked effect of traumatic bleeding, preoperative preventive medication may reduce surgical bleeding
|
 |
CAS No. 1197-18-8
EINECS No. :214-818-2
Molecular Formula: C8H15NO2
MW: 157.21
Molecular structure:
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
